Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6595462

CN(C)Cc1ccncc1N.O=C(O)C(F)(F)F

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AOC1 P19801 2/20 0.44
AOC3 Q16853 2/20 0.44
ALDH1A1 P00352 3/20 0.41
KDM4E B2RXH2 2/20 0.41
MAPT P10636 2/20 0.41
MEN1 O00255 1/20 0.41
KDM6B O15054 1/20 0.41
KDM4A O75164 1/20 0.41
THRB P10828 1/20 0.41
KMT2A Q03164 1/20 0.41
KDM4D Q6B0I6 1/20 0.41
KDM4C Q9H3R0 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
GLA P06280 1/20 0.38
GAA P10253 1/20 0.38
SLC6A4 P31645 4/20 0.35
SLC6A2 P23975 3/20 0.35
GPBAR1 Q8TDU6 3/20 0.35
CHRNB2 P17787 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6035134 0.84 AOC1 (0.59) AOC1AOC3ALDH1A1KDM4EMAPT
Trifluoroacetic Acid SCHEMBL8375149 0.72 L3MBTL1 (0.42) ALDH1A1KDM4EMAPTMEN1KDM6B
SCHEMBL23540496 0.72 AOC1 (0.47) AOC1AOC3ALDH1A1KDM4EMAPT
SCHEMBL30015187 0.72 AOC1 (0.47) AOC1AOC3ALDH1A1KDM4EMAPT
SCHEMBL2999880 0.70 AOC1 (0.53) AOC1AOC3ALDH1A1KDM4EMAPT
SCHEMBL30210557 0.70
SCHEMBL5748797 0.70
SCHEMBL3326582 0.70 AOC1 (0.57) AOC1AOC3ALDH1A1KDM4EMAPT
Trifluoroacetic Acid SCHEMBL8375150 0.69 KDM4E (0.39) ALDH1A1KDM4EMAPTMEN1KDM6B
SCHEMBL23674697 0.69 KDM4C (0.49) ALDH1A1KDM4EMAPTMEN1KDM6B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1414801-A1 ARYLAMINES FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH GSK-3 AstraZeneca AB (SE) 2004-05-06 EP disclosed
WO-2003004472-A1 ARYLAMINES FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH GSK-3 ASTRAZENECA AB (SE) 2003-01-16 WO disclosed